Failure of serum β2-microglobulin levels as an early marker of preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 3, 2000, Pages 595-598

  Haddad, Bassam ^a   Desvaux, Dominique ^a   Livingston, Jeffrey C ^a   Barranger, Emmanuel ^a   Paniel, Bernard J ^a   Sibai, Baha M ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Prediction; Preeclampsia; 2 Microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CREATININE; URIC ACID;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; PREECLAMPSIA; PREMATURE LABOR; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; PREDICTION AND FORECASTING; PREGNANCY; PROSPECTIVE STUDY;

ADULT; BETA 2-MICROGLOBULIN; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; FEMALE; HUMANS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; URIC ACID;

EID: 0033621861     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.103940     Document Type: Article

References (16)

1. 1. Grimes DA. The morbidity and mortality of pregnancy: still risky business. Am J Obstet Gynecol 1994;170:1489-94.
2. 2. Kaunitz AM, Hughes JM, Grimes DA, Smith JC, Rochat RW, Kafrissen ME. Causes of maternal mortality in the United States. Obstet Gynecol 1985;65:605-12.
3. 3. Knutzen VK, Davey DA. Hypertension in pregnancy: perinatal mortality and causes of fetal death. S Afr Med J 1977;51:675-9.
4. 4. Sheppard BL, Bonnar J. An ultrastructural study of uteroplacental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 1981;88:695-705.
5. 5. Khong TY, De Wolf F, Robertson WB, Brossen I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049-59.
6. 6. Dekker GA, Sibai BM. Early detection of preeclampsia. Am J Obstet Gynecol 1991;165:160-72.
7. 7. Gonen R, Perez R, David M, Dar H, Merksamer R, Shad M. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol 1992;80:83-6.
8. 8. Conde-Agudelo A, Lede R, Belizán J. Evaluation of methods used in prediction of hypertensive disorders of pregnancy. Obstet Gynecol Surv 1994;49:210-22.
9. 9. Muller F, Savey L, Le Fiblec B, Bussières L, Ndayizamba G, Colau JC, Giraudet P. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol 1996;175:37-40.
10. 10. Wenstrom KD, Owen J, Davis RO, Brumfield CG. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein. Obstet Gynecol 1996;87:213-6.
11. 11. Morssink LP, Heringa MP, Beekhuis JR, DeWolf BT, Mantingh AT. The association between hypertensive disorders of pregnancy and abnormal second-trimester maternal serum levels of hCG and alpha-fetoprotein. Obstet Gynecol 1997;89:666-70.
12. 12. Berggard I, Bearn AG. Isolation and properties of a low molecular weight beta-2-globulin occurring in human biological fluids. J Biol Chem 1968;243:4095-103.
13. 13. Schardijn GH, Statius van Eps LW. Beta 2-microglobulin: its significance in the evaluation of renal function. Kidney Int 1987;32:635-41.
14. 14. Oian P, Monrad-Hansen HP, Maltau JM. Serum uric acid correlates with beta 2-microglobulin in pre-eclampsia. Acta Obstet Gynecol Scand 1986;65:103-6.
15. 15. Saudan PJ, Farrell TJ, Brown MA. Beta2-microglobulin in hypertensive pregnancies. Am J Kidney Dis 1998;31:308-12.
16. 16. Krieger MS, Moodley J, Norman RJ, Jialal I. Reversible tubular lesion in pregnancy-induced hypertension detected by urinary beta 2-microglobulin. Obstet Gynecol 1984;63:533-6.